JOIN TSF'S 5KDonate to IlluminateContact TSF
Facebook Logo Twitter Logo Youtube Logo Instagram Logo LinkedIn Logo TikTok Logo Blue Sky Logo

Understanding Clinical Trials for MOGAD & the Importance of Patient Participation

Virtual: Danmark , Denmark

You're invited to join TSF's 1st live webinar of 2023 - Understanding Clinical Trials for MOGAD & the Importance of Patient Participation - on Friday, January 6th featuring Dr. Michael Levy who will share updates about ongoing clinical trials for patients living with MOGAD. Additionally, we will discuss the importance and value of patient participation […]

Human Collective Project

TSF Plauderstunde | HCP Germany

Virtual: Danmark , Denmark

The Human Collective Project (HCP) is TSF’s support group meetings offered to anyone who has been affected/impacted by NMOSD/MOG-AD. The program came into existence during the height of the COVID-19 […]

Young People’s Webinar | Connecting MS, NMOSD & MOGAD: Sharing Knowledge and Experiences to Strengthen Our Communities

Virtual: Danmark , Denmark

There are a number of different autoimmune disorders with similar features to Multiple Sclerosis (MS), such as neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody disorder (MOGAD). These diseases share striking similarities that ultimately affect the way in which our communities understand and manage the diagnosis. Hence, it is of utmost importance for […]

Human Collective Project

TSF Plauderstunde | HCP Germany

Virtual: Germany , Germany

The Human Collective Project (HCP) is TSF’s support group meetings offered to anyone who has been affected/impacted by NMOSD/MOGAD. The program came into existence during the height of the COVID-19 […]

From The Experts

NMOSD, MOGAD und MS: Gemeinsamkeiten und Unterschiede

Virtual: Germany , Germany

Herzliche Einladung zum ersten Live-Webinar "NMOSD, MOGAD und MS: Gemeinsamkeiten und Unterschiede" der Sumaira-Foundation für die deutschsprachige NMOSD & MOGAD Community am Montag, den 13. Februar, mit Dr. Joachim Havla, Neurologe und NMOSD/MOGAD-Spezialist an der Ludwig-Maximilians-Universität München. Dr. Havla wird die Gemeinsamkeiten und Unterschiede zwischen NMOSD, MOGAD und die Abgrenzung gegenüber der Multiplen Sklerose erläutern. […]

Industry Partners

Community Partners

WARNING: Internet Explorer does not support modern web standards. This site may not function correctly on this browser and is best viewed on Chrome, Firefox or Edge browsers. Learn More.